Morgan Stanley’s PEDEVCO PED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.02K Buy
+376
New +$4.93K ﹤0.01% 7092
2023
Q4
Sell
-50
Closed -$1.01K 7888
2023
Q3
$1.01K Hold
50
﹤0.01% 7230
2023
Q2
$915 Hold
50
﹤0.01% 7307
2023
Q1
$1.06K Hold
50
﹤0.01% 7345
2022
Q4
$1.1K Hold
50
﹤0.01% 7458
2022
Q3
$1K Sell
50
-9,772
-99% -$218K ﹤0.01% 7587
2022
Q2
$226K Sell
9,822
-11,194
-53% -$287K ﹤0.01% 5835
2022
Q1
$567K Sell
21,016
-12,884
-38% -$341K ﹤0.01% 5333
2021
Q4
$719K Buy
33,900
+31,144
+1,130% +$865K ﹤0.01% 5317
2021
Q3
$82K Buy
2,756
+806
+41% +$19.9K ﹤0.01% 6480
2021
Q2
$62K Buy
+1,950
New +$54.9K ﹤0.01% 6574
2020
Q1
Sell
-9
Closed 6666
2019
Q4
$0 Buy
+9
New +$265 ﹤0.01% 6731
2018
Q1
Sell
-66
Closed 6671
2017
Q4
$0 Buy
+66
New +$455 ﹤0.01% 6622
2015
Q2
Sell
-6
Closed -$1K 6719
2015
Q1
$1K Buy
+6
New +$713 ﹤0.01% 6491
2014
Q3
Sell
-48
Closed -$20K 6635
2014
Q2
$20K Buy
+48
New +$19.6K ﹤0.01% 6029

Other funds holding PED

Morgan Stanley's PED Position: Q1 2026 in Review

Morgan Stanley opened a new position in PEDEVCO (PED) in Q1 2026: 376 shares worth $6.02K. The stake represents ﹤0.01% of the portfolio and ranks #7092 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in PED as recently as Q3 2023.

Morgan Stanley first reported a position in PED in Q2 2014 and has held it in 15 quarters since. The position peaked at $719K in Q4 2021. 15 funds tracked by Wall St. Rank hold PED as of Q1 2026.

  • Morgan Stanley held 376 shares of PEDEVCO worth $6.02K as of Q1 2026.
  • PEDEVCO was a new Morgan Stanley position in Q1 2026.
  • PEDEVCO made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7092 holding.
  • Morgan Stanley first reported a position in PEDEVCO in Q2 2014 and has held it in 15 quarters since.
  • Morgan Stanley's PEDEVCO position peaked at $719K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held PEDEVCO as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.